Ardelyx, Inc. Profile Avatar - Palmy Investing

Ardelyx, Inc.

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which h…

Biotechnology
US, Waltham [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Ardelyx, Inc. has no acquisition track records yet.

M&A Deals · History

Ardelyx, Inc. has no acquisition track records yet.

End of ARDX's Analysis
CIK: 1437402 CUSIP: 039697107 ISIN: US0396971071 LEI: - UEI: -
Secondary Listings
ARDX has no secondary listings inside our databases.